Skip to main content

Marc Ribó Jacobi

Institutions of which they are part

Main researcher
Stroke research
Vall Hebron Institut de Recerca

Marc Ribó Jacobi

Institutions of which they are part

Main researcher
Stroke research
Vall Hebron Institut de Recerca

Projects

Early identification of intracranial atherosclerosis-related large vessel occlusion (ICAS-LVO) and implications in endovascular treatment

IP: Marc Ribó Jacobi
Collaborators: Marc Rodrigo Gisbert
Funding agency: Fundació Institut de Recerca HUVH
Funding: 59681.19
Reference: DORADO/2024/RODRIGO
Duration: 08/06/2024 - 07/06/2026

Aplicación de estrategias para agilizar el tratamiento de pacientes con ictus agudo

IP: Marc Ribó Jacobi
Collaborators: Marta Olive Gadea, Miriam Izquierdo Sans
Funding agency: Instituto de Salud Carlos III
Funding: 65000
Reference: CM23/00280
Duration: 31/03/2024 - 30/03/2026

NexTOLL: A Phase IIb Clinical Trial to evaluate the neuroprotective effect of ApTOLL in stroke patients

IP: Marc Ribó Jacobi
Collaborators: Marta Aurora Rubiera Del Fueyo, Jorge Pagola Pérez Blanca, Carlos Molina Cateriano, Mª Ángeles Muchada López
Funding agency: Ministerio de Ciencia e Innovación-MICINN
Funding: 498435
Reference: CPP2022- 009778
Duration: 09/03/2023 - 08/03/2026

Ministerio de Ciencia

ARTERIAL: una herramienta de inteligencia artificial para la planificación del tratamiento endovascular del ictus.

IP: Marc Ribó Jacobi
Collaborators: Miriam Izquierdo Sans
Funding agency: Instituto de Salud Carlos III
Funding: 60000
Reference: INT22/00109
Duration: 01/01/2023 - 31/12/2024

Related news

UMBRELLA, a consortium of over 20 public and private partners, kicks off this week with the aim of revolutionising the entire stroke care pathway in Europe by adopting a holistic approach that covers stroke diagnosis, prevention and care.

The Consortium will create a platform to facilitate a personalised management for stroke patients, enabling a more efficient personalized monitoring and patient follow up.

Funding is key to bringing the neuroprotective drug ApTOLL to market and providing a new therapeutic option for the patients.

Related professionals

Navajo Garrido, Rafael José

Navajo Garrido, Rafael José

Director/a d'Àrea
Innovation and Technology Transfer Directorate
Read more
Perez Garcia, Lidia

Perez Garcia, Lidia

Administration and Management
Read more
Gabriela Gomez Andrade

Gabriela Gomez Andrade

Research technician
Biomedical Research in Melanoma
Read more
Jerez  Cayuela, Andrés

Jerez Cayuela, Andrés

Main researcher
Read more

Subscribe to our newsletters and be part of the Campus life

We are a world-leading healthcare complex where healthcare, research, teaching and innovation go hand in hand.

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.